Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Hong Kong · Delayed Price · Currency is HKD

0.1600

+0.0020 (1.27%)

Jul 10, 2026, 4:08 PM HKT

-20.79% (1Y)

Market Cap	325.26M -14.4%
Revenue (ttm)	2.32B -26.1%
Net Income	38.78M -17.1%
EPS	0.02 -15.0%
Shares Out	2.03B
PE Ratio	8.46
Forward PE	n/a
Dividend	0.00 (1.04%)
Ex-Dividend Date	May 19, 2026

Volume	20,000
Open	0.1580
Previous Close	0.1580
Day's Range	0.1580 - 0.1600
52-Week Range	0.1490 - 0.2800
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About HKG:6833

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers human albumin serum under the Octapharma, Octapamma, and Octenor name for the treatment of premature infants, hypovolemia, hypoproteinemia, neonatal hyperbilirubinemia, acute respiratory distress syndrome, cardiopulmonary bypass, special types of hemodialysis, and plasma exchange. It also provides Axetine, which is used for the ... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2011

Employees 261

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6833

Full Company Profile

Financial Performance

In 2025, HKG:6833's revenue was 2.08 billion, a decrease of -26.11% compared to the previous year's 2.82 billion. Earnings were 34.85 million, a decrease of -17.11%.

Financial numbers in CNY Financial Statements